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Summary
Background: In response to DNA damage, cells activate
checkpoints to halt cell-cycle progression and prevent
genomic instability. Checkpoint activation induced by DNA
double-strand breaks (DSB) is dependent on the ATM kinase,
a master regulator of the DNA damage response (DDR) that is
activated through autophosphorylation and monomerization.
Results:Here we show that either protein phosphatase 1 or 2A
is sufficient to suppress activation of the DDR and that simul-
taneous inhibition of both phosphatases fully activates the
response. PP1-dependent DDR regulation is mediated by its
chromatin-targeting subunit, Repo-Man. Studies in Xenopus
egg extracts demonstrate that Repo-Man interacts with ATM
and PP1 through distinct domains, leading to PP1-dependent
regulation of ATM phosphorylation and activation. Conse-
quently, the level of Repo-Man determines the activation
threshold of the DNA damage checkpoint. Repo-Man interacts
and extensively colocalizes with ATM in human cells. Expres-
sion of wild-type, but not PP1 binding-deficient, Repo-Man
attenuates DNA damage-induced ATM activation. Moreover,
Repo-Man dissociates from active ATM at DNA damage sites,
suggesting that activation of the DDR involves removal of
inhibitory regulators. Analysis of primary tumor tissues and
cell lines demonstrates that Repo-Man is frequently upregu-
lated in many types of cancers. Elevated Repo-Man expres-
sion blunts DDR activation in precancerous cells, whereas
knockdown of Repo-Man in malignant cancer cells resensi-
tizes the DDR and restrains growth in soft agar.
Conclusions:We report essential DDR regulation mediated by
Repo-Man-PP1 and further delineate underlying mechanisms.
Moreover, our evidence suggests that elevated Repo-Man
contributes to cancer progression.
Introduction
To protect genomic integrity after DNA damage, cells have
evolved surveillance mechanisms, generally termed the
‘‘DNA damage response (DDR),’’ that encompass both DNA
repair and signal transduction pathways, activating cell-cycle
checkpoints and arresting cell-cycle progression [1, 2]. The
DDR to DNA double-strand break (DSB) is initiated by acti-
vation of the ataxia telangiectasia mutated (ATM) Ser-Thr
kinase, which triggers multiple mechanisms of signal amplifi-
cation. Activation of ATM involves intermolecular autophos-
phorylation so that a small pool of activated ATM at the site*Correspondence: jim.maller@ucdenver.eduof DSBs rapidly induces ATM autophosphorylation throughout
the cell [3]. Moreover, ATM anchoring to chromatin by
g-H2AX and adaptors, such as Mdc1 and the Mre11-Rad50-
Nbs1 complex, results in expansion of H2AX phosphorylation
to large chromatin regions flanking DSBs [4]. A potential
consequence of these amplification mechanisms is that
minimal DNA damage may eventually cause full activation of
the DDR. However, recent studies indicate that a threshold
level of DNA damage has to be reached for the checkpoint to
affect cell-cycle progression. In Xenopus, 2–4 ng/ml of
damaged DNA is required to elicit DNA damage checkpoint
signaling in egg extracts and to slow cleavage cycles in
embryos [5, 6]. Similarly, a defined G2/M checkpoint
threshold of 10–20 DSBs per cell has been reported in human
cells, and DNA damage below that threshold level neither effi-
ciently activates the checkpoint nor sustains it prior to comple-
tion of DNA repair [7, 8]. It is currently unclear how DNA
damage thresholds are achieved and regulated; a credible
speculation is that cells have evolved inhibitory mechanisms
to prevent checkpoint activation by a subthreshold level of
DNA damage.
Recently, several Ser-Thr protein phosphatases have been
found responsible for deactivation of the DNA damage check-
point during recovery from cell-cycle arrest [9–11]. A well-
studied example is PP2Cd/Wip1, which has been shown to
dephosphorylate multiple phospho-S/TQ sites targeted by
ATM or ATR, including those in ATM itself and its substrates
[12, 13]. Also connected to the checkpoint recovery pathway
are PP1 and PP2A, which together account for 95% of total
cellular Ser-Thr phosphatase activity. Unlike Wip1 or other
PP2C family members, specific functions of PP1 and PP2A
are conferred by additional targeting subunits that control their
subcellular localization and substrate specificity [10, 11].
Studies in yeast and mammalian cells show that specific
PP2A and PP4 (PP2A-like) complexes are responsible for
g-H2AX dephosphorylation during checkpoint recovery
[14–16]. The involvement of PP1 in checkpoint recovery is
less well studied, but in S. pombe, dephosphorylation of
Chk1 by Dis2 (a PP1 homolog) allows mitotic entry upon
completion of DNA repair in G2 [17]. The specific targeting
subunit in yeast or higher eukaryotes that mediates PP1 regu-
lation of DDR factors has yet to be identified.
Given that activation of the DDR relies on protein phos-
phorylation by ATM and other kinases, it is possible that
protein phosphatases, particularly PP1 and PP2A, create
a sensitivity threshold for DNA damage checkpoint activation
in addition to promoting checkpoint recovery. In this
study, we show that the chromatin-bound Repo-Man-PP1g
complex modulates ATM activation, thereby setting the
threshold for checkpoint activation. Importantly, Repo-Man
(recruits PP1 onto mitotic chromatin at anaphase, also known
as Cdca2) is frequently upregulated in various cancers, and
overexpression is both necessary and sufficient for reduced
DDR sensitivity during cancer progression. Reduction of
Repo-Man expression attenuates growth of breast cancer
cells in soft agar, arguing that upregulation of Repo-Man is
essential for anchorage-independent growth of at least some
tumor cells.
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Figure 1. Inhibition of PP1 Enhances DNA Damage Checkpoint Signaling
(A) Interphase Xenopus egg extracts containing 1000 sperm nuclei/ml were
treated with microcystin (MC) at 3 mM, okadaic acid (OA) at 2 or 0.4 mM
(marked as H or L), or Inhibitor-2 (I-2) at 0.4 mM as indicated and analyzed
by western blotting with the indicated antibodies.
(B and C) Interphase egg extracts as in (A) were mock (buffer) or I-2 treated
and then supplemented with EcoR1-linearized pGEX 4T-1 plasmid (cut
plasmid) DNA (B) or a double-stranded oligonucleotide (dA-dT) (C) at the
indicated concentrations. Samples were then analyzed by western blotting
as indicated. See also Figure S1.
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PP1 and PP2A Both Regulate DNA Damage Response
Activation
PP1 and PP2A are the two major forms of Ser-Thr phospha-
tase in Xenopus egg extracts [18, 19]. To investigate whether
PP1 and PP2A are required to suppress DDR activation, we
utilized microcystin-LR (MC) to inhibit PP1 and PP2A phos-
phatases in undamaged Xenopus egg extracts, which have
been widely used to study the DDR [20, 21]. Quite strikingly,
MC induced robust phosphorylation of Smc1, H2AX, Chk1,
Chk2, and Mre11, as judged by phospho-antibody blotting or
retarded electrophoretic mobility (Figure 1A). Okadaic acid
(OA) at 2 mM inhibits most PP2A and PP1 activity [18, 22] and
was sufficient to activate responses similar to those induced
by MC (Figure 1A). In contrast, OA at 0.4 mM that inhibits only
PP2A activity [18, 22], or Inhibitor-2 (I-2) at 0.4 mM that specif-
ically inhibits PP1 [23], did not elicit significant activation of
Smc1, Chk1, Chk2, or Mre11 phosphorylation, despite minimal
H2AX phosphorylation (Figure 1A). Interestingly, extracts
treated with both OA at 0.4 mM and I-2 exhibit strong phos-
phorylation of Smc1, Chk1, Chk2, H2AX, and Mre11 (Fig-
ure 1A). Taken together, these results indicate that both PP1
and PP2A are involved in DDR regulation. Either PP1 or
PP2A alone is sufficient to suppress spontaneous DDR activa-
tion, and inhibition of both phosphatases synergistically
induces DDR signaling without actual DNA damage. The crit-
ical involvement of PP1 in DDR regulation is also supported
by evidence that PP1 inhibition sensitizes DDR activation.
When Xenopus egg extracts were supplemented with I-2 to
inhibit PP1, we observed an elevated response to low-dose
DNA damage, added as either cut plasmid DNA (Figure 1B)
or double-stranded oligonucleotides (Figure 1C).
Repo-Man Recruits PP1 to Chromatin to Suppress DNA
Damage Response Activation
MC-induced Chk2 and Chk1 phosphorylation was more
pronounced in extracts supplemented with sperm DNA (see
Figure S1A available online), which itself is undamaged and
does not activate the checkpoint on its own [6]. The DNA
dependence of MC-induced Chk1 and Chk2 phosphorylation
suggests that inhibition of protein phosphatases produces
chromatin-based signal transduction like that induced by
actual DNA damage [24]. An attractive hypothesis is that
a chromatin-bound protein phosphatase suppresses DDR
activation and that its inhibition promotes DDR signaling on
chromatin. The g isoform of PP1 has been reported to be
present on chromatin [25], and we confirmed that a portion
of PP1g binds to chromatin in Xenopus egg extracts, whereas
neither PP1a nor PP2A were detectable on chromatin
(Figure S1B). To investigate the relevance of PP1g to activation
of the DNA damage checkpoint, we immunodepleted PP1g
from egg extracts and observed that the extracts became
more sensitive to DNA damage, whereas add-back of
recombinant PP1g abolished the hypersensitivity (Figures 2A
and 2B). These results suggest that PP1g is involved in
suppression of DNA damage signaling.
Unlike other protein phosphatases, specific functions of
PP1 are achieved through interactions with targeting subunits
that contain a consensus PP1-interacting motif, RVxF [10].
A PP1g-specific interacting protein, Repo-Man, has been
reported to recruit PP1g onto mitotic chromosomes [26, 27].
The interaction between Repo-Man and PP1g persists through
interphase, implying that Repo-Man could also be responsiblefor chromatin localization of PP1g in interphase [26]. We
cloned the Repo-Man homolog in Xenopus (GenBank acces-
sion number FJ532285) and raised an antibody against its
C terminus (Figures S2A–S2C). Affinity-purified PP1g antibody
coimmunoprecipitated Repo-Man from interphase egg
extracts, confirming interaction between PP1g and Repo-
Man in Xenopus (Figure S2D). Furthermore, specific chromatin
binding of PP1g and Repo-Man was evident in Xenopus egg
extracts (Figure S2G), whereas knockdown of endogenous
Repo-Man with antisense oligonucleotides (Figure S2C) or
disruption of Repo-Man-PP1g interaction with a consensus
RVTF peptide (Figures S2E and S2F) reduced binding of
PP1g to chromatin (Figure S2H). We thus confirm in Xenopus
that Repo-Man interacts with PP1 through its RVTF motif
and recruits PP1 onto chromatin. Importantly, addition of the
RVTF peptide, but not the control RATA peptide, led to Chk1
and Smc1 phosphorylation with a lower dose of damaged
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Figure 2. Repo-Man/PP1g Regulates DNA
Damage Checkpoint Activation
(A) Extracts were mock treated with beads alone
(2), immunodepleted of PP1g with anti-PP1g
beads (Dep), or PP1g-depleted and then recon-
stituted with purified recombinant His6-PP1g
(Add-back). The level of PP1g was monitored
by western blotting, and a nonspecific band
served as a loading control.
(B) Extracts in panel (A) were supplemented with
cut plasmid DNA at the indicated concentrations
and monitored by western blotting as indicated.
Depletion of PP1g increased DNA damage
response (DDR) signaling.
(C) Egg extracts were supplemented with water
(2), RATA, or RVTF peptides (Figure S2B) and
then treated with or without 0.4 ng/ml of cut
plasmid DNA and analyzed by western blotting.
Disruption of PP1g binding by the RVTF peptide
increased the DDR.
(D) Immature Xenopus oocytes were preinjected
with mRNA encoding full-length wild-type (WT)
or mutant (AA) Repo-Man and incubated over-
night. Oocyte extracts were prepared and sup-
plemented with 2 ng/ml of cut plasmid DNA with
or without 10 mM caffeine, an ATM inhibitor,
and analyzed by western blotting.
(E and F) Oocytes were preinjected with two
different Repo-Man antisense oligonucleotides
(1 and 2), a control (c) oligonucleotide (E), or
Repo-Man mRNA (F) and incubated overnight. Oocyte extracts were prepared and supplemented with cut plasmid DNA for 30 min, followed by western
blotting of the indicated proteins.
(G) Immature Xenopus oocytes preinjected with an antisense oligonucleotide (Figure 2E, ‘‘2’’) to knock down (KD) Repo-Man or with mRNA to overexpress
(OE) Repo-Man were incubated overnight and then injected again with the indicated concentrations of cut plasmid DNA. Oocytes were then stimulated
with progesterone to undergo M-phase progression, and after 200 min the percentage of oocytes that remained blocked in interphase was scored. The
mean 6 standard error of the mean (SEM) (n = 3) of replicate experiments is shown. See also Figures S1 and S2.
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389DNA (Figure 2C). In addition, expression of a mutant Repo-
Man, in which the RVTF motif was changed to RATA, also
reduced PP1 association (Figure 3A) and enabled Smc1 phos-
phorylation with a lower amount of damaged DNA (Figure 2D).
The enhanced response was DNA damage induced and
caffeine sensitive, confirming that it results from ATM- or ATR-
dependent signal transduction (Figure 2D). Moreover, reducing
the level of Repo-Man expression with two different antisense
oligonucleotides increased sensitivity to DNA damage in
a fashion correlated with the efficiency of the knockdown (Fig-
ure 2E). Conversely, ectopic expression of Repo-Man sup-
pressed DNA damage-induced signaling in egg extracts, as
shown by phosphorylation of Smc1 (Figure 2F). To assess
DNA damage checkpoint activation by induction of cell-cycle
arrest in vivo, we studied progesterone-induced Xenopus
oocyte maturation, a model of the G2/M transition. Injection
of damaged DNA activated the checkpoint and blocked the
transition to M phase (Figure S2I). When the Repo-Man level
was reduced by antisense oligonucleotides, the minimal
amount of DNA damage required to affect cell-cycle progres-
sion was lowered, whereas oocytes with overexpressed
Repo-Man underwent maturation despite the presence of
DNA damage at doses sufficient to activate the checkpoint in
control oocytes (Figure 2G). Therefore, these results establish
Repo-Man as a negative regulator of the DDR. By targeting
PP1g to chromatin to inhibit checkpoint signaling, Repo-Man
dictates the cellular response to low-dose DNA damage and
sets a threshold for checkpoint activation.
Repo-Man Targets PP1 to Modulate ATM Activation
Among components of the DNA damage signaling pathway,
especially those that bind to chromatin, we observed thatATM, but not Chk1 or H2AX, was copurified from egg extracts
in a pull-down assay with His-tagged Repo-Man, wild-type or
mutated in the PP1 binding site (Figures 3A and 3B), suggest-
ing that Repo-Man association with ATM is independent of its
association with PP1. The extracts were not supplemented
with sperm DNA, and thus Repo-Man-PP1 association is not
mediated by chromatin. The interaction was confirmed with
endogenous Repo-Man and ATM coimmunoprecipitation in
Xenopus egg extracts (Figure 3C). The ATM-interacting
domain of Repo-Man was mapped to its C terminus, whereas
the middle part of Repo-Man, which contains the RVTF motif,
was sufficient to bind PP1g (Figure 3D). By binding to PP1g in
one region of the molecule and to ATM in another, Repo-Man
acted as a bridge for PP1-ATM interaction, which was reduced
in extracts with Repo-Man knockdown (Figure S3A). In light of
DDR regulation by protein phosphatases, we speculate that
Repo-Man brings PP1g adjacent to ATM, leading to regulation
of ATM. ATM autophosphorylated at Ser 1981 was efficiently
dephosphorylated by PP1g in vitro (Figure S3B), and, more
importantly, extracts with a reduced level of Repo-Man ex-
hibited augmented ATM autophosphorylation with or without
DNA damage (Figure 3E, top). Consistently, ATM kinase
activity in extracts was enhanced by Repo-Man knockdown
(Figure 3E, bottom). Taken together, our evidence pinpoints
ATM as a key substrate of the Repo-Man-PP1g enzymatic
complex.
Repo-Man Is Associated and Colocalized with ATM
and Regulates ATM Activation in Human Cells
The interaction between ATM and Repo-Man identified in
Xenopus egg extracts (Figures 3A–3D) is conserved in
human cells. As shown in Figure 4A, Repo-Man
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Figure 3. Repo-Man Targets PP1g to Regulate ATM
(A and B) His-tagged AA mutant (A) or wild-type (B)
Repo-Man was expressed by adding mRNAs into Xeno-
pus egg extracts, as described in the Supplemental
Experimental Procedures, and then reisolated on Talon
beads (right). Ten percent control extract without addi-
tion of mRNA was loaded in the left column as an input
control; the middle shows a parallel pull-down in the
control extract. The beads were eluted in sample buffer
and blotted with the indicated antibodies. ATM was
pulled down with Repo-Man.
(C) Immunoprecipitation (IP) was performed in egg
extracts with Repo-Man antibody, and samples were
analyzed by western blotting with the indicated anti-
bodies. The left column is a 10% extract input control.
ATM was copurified with Repo-Man.
(D) Three segments of Repo-Man (N, M, and C, as indi-
cated) were subcloned, bacterially expressed with an
N-terminal GST tag, and purified on glutathione Sephar-
ose beads. The beads were then used for a pull-down
assay in egg extracts, eluted with sample buffer, and
analyzed by Coomassie staining and western blotting.
ATM and PP1g bind to C and M regions of Repo-Man,
respectively.
(E) Top: Xenopus oocytes were injected with Repo-Man
antisense oligonucleotides, incubated overnight, and
subjected to a second injection of water or 5 ng damaged
DNA (dA-dT). The oocytes were incubated for 30 min and
homogenized, and extracts were analyzed by western
blotting for ATM and its autophosphorylation at Ser 1981.
Bottom: the same oocyte extracts were also analyzed by
an in vitro kinase assay for ATM kinase activity, as
described in the Supplemental Experimental Procedures.
Relative activities are shown as mean 6 SEM (n = 3) of
replicate experiments. Repo-Man knockdown resulted
in a higher level of ATM activation in vivo. See also
Figure S3.
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390coimmunoprecipitated with ATM in nontumorigenic human
MCF10A epithelial cells. To study the subcellular localization
of ATM and Repo-Man, we first extracted MCF10A cells to re-
move soluble but not chromatin-bound proteins and then
immunostained for ATM or Repo-Man. Chromatin-bound
ATM extensively colocalized with Repo-Man (Figure 4B).
Generation of chromatin fibers provided higher resolution for
studying chromatin localization of proteins, and the same
pattern of chromatin distribution was observed for ATM and
Repo-Man on chromatin fibers (Figure 4C). The specificity of
the Repo-Man immunostaining of cells and chromatin fibers
was confirmed in Figure S4. Our studies in Xenopus egg
extracts and oocytes show that Repo-Man targets PP1 to
regulate ATM phosphorylation and activation (Figure 2). This
function is also conserved in human cells. Ectopic expression
of Repo-Man tagged by GFP reduced etoposide-induced ATM
activation, as judged by the different level of ATM autophos-
phorylation at Ser 1981 in GFP-positive and control cells
(Figure 4D, top). In agreement with the PP1 dependence of
this regulation, similar expression of a PP1 binding-deficient
Repo-Man mutant (AA), in which the RVTF binding motif was
mutated to RATA, did not reduce DNA damage-induced ATM
activation, but instead further stimulated the response
(Figure 4D, bottom).
Repo-Man Is Dissociated from Active ATM at DNA Damage
Sites
In Xenopus egg extracts, chromatin association of both Repo-
Man and PP1g was reduced by high-dose Neocarzinostatin
(NCS), a DNA-damaging agent known to cause DSBs ongenomic DNA [28] (Figure 5A). On the other hand, chromatin
binding of ATM increased after DNA damage, possibly reflect-
ing recruitment to DNA damage sites (Figure 5A). A similar
dissociation of Repo-Man from chromatin after DNA damage
was observed in MCF10A cells (Figure 5B). An interesting
hypothesis is that release of Repo-Man near DNA damage sites
facilitates activation of the DDR, and consequently, active ATM
at DNA damage sites may not be associated with or inhibited by
Repo-Man. To test this idea, we subjected MCF10A cells to
DNA damage, extracted them to remove soluble proteins,
and immunostained the residual chromatin for active ATM
and Repo-Man. In contrast to extensive colocalization between
ATM and Repo-Man in unperturbed cells (Figures 4B and 4C),
Repo-Man did not colocalize with active, phosphorylated
ATM (Figure 5C). Measurement of fluorescence intensity
further suggests that the level of Repo-Man was generally
reduced at foci where active ATM was concentrated (Figure 5C,
bottom). These foci have been shown to reflect DNA damage
sites where many DDR factors are recruited [29], and thus the
removal of Repo-Man from these areas supports our hypoth-
esis. Another line of supporting evidence was provided by im-
munostaining of chromatin fibers. As previously shown [30],
double-strand breaks are not directly visible but can be marked
on chromatin fibers by detection of DDR factors. Interestingly,
Repo-Man is excluded from chromatin domains enriched with
active ATM (Figure 5D). Dissociation of Repo-Man from active
ATM was also directly monitored by immunoprecipitation
with phospho-specific ATM pS1981 antibody. As shown in
Figure 5E, Repo-Man did not coimmunoprecipitate with phos-
pho-ATM in DNA damage-treated cells.
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Figure 4. Repo-Man Associates with ATM and Regulates Its Activation in
Human Cells
(A) Immunoprecipitation (IP) was performed in MCF10A cell extracts with
control agarose beads (beads) or beads conjugated to ATM antibody
(beads-ATM). The immunoprecipitates and 10% cell extract input were
analyzed by western blotting for ATM and Repo-Man.
(B) Top: MCF10A cells were extracted, immunostained for ATM and Repo-
Man, and costained with DAPI. Bottom: red and green curves represent
fluorescence intensity in corresponding colors following the black trail
marked on the merged panel.
(C) Chromatin fibers were generated from MCF10A cells, immunostained for
ATM and Repo-Man, and costained with DAPI.
(D) MCF10A cells were infected with recombinant adenovirus expressing
GFP-wild-type Repo-Man or GFP-RATA mutant Repo-Man. These cells
were then treated with 500 nM etoposide for 2 hr and analyzed by direct fluo-
rescence (green) for GFP and indirect immunofluorescence (red) for ATM
pS1981. See also Figure S4.
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Figure 5. Dissociation of Repo-Man from Chromatin and Active ATM at DNA
Damage Sites
(A) Xenopus egg extracts were treated with water (2) or 20 mg/ml Neocarzi-
nostatin (NCS) for 10 min or 1 hr. Chromatin fractions were isolated from the
extracts by centrifugation and analyzed by western blotting. DNA damage
induced partial dissociation of Repo-Man and PP1g from chromatin,
whereas ATM was recruited to chromatin.
(B) MCF10A cells were treated with water or 2 mg/ml NCS for 2 hr. Chromatin
fractions (top panels) and total extracts (bottom) were analyzed by western
blotting as indicated.
(C) Top: MCF10A cells were treated with 1 mM etoposide for 2 hr, extracted,
immunostained for ATM pS1981 and Repo-Man, and costained with DAPI.
Bottom: red and green curves represent fluorescence intensity in corre-
sponding colors following the white trail marked on the merged panel.
(D) Chromatin fibers were generated from MCF10A cells, immunostained for
ATM pS1981 and Repo-Man, and costained with DAPI.
(E) Immunoprecipitation (IP) was performed in etoposide-treated MCF10A
cell extracts with ATM pS1981 antibody (middle). A similar IP with nonim-
mune IgG served as a negative control (left), and an IP with total ATM anti-
body in undamaged cell extracts served as a positive control (right). The
immunoprecipitates were analyzed by western blotting for ATM and
Repo-Man.
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391Expression of Repo-Man Is Frequently Elevated
in Cancer Cells
Repo-Man was first identified as a gene whose expression
correlates with known cell-cycle genes [31]. More recently, it
has been classified by two independent high-throughput
screens into a unique group of genes that are upregulated
during progression of neuroblastomas and melanomas
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Figure 6. Overexpression of Repo-Man during Tumor
Progression Blunts the DNA Damage Response
(A) The MCF10A parental cell line and its progressively more
oncogenic variants (T1k, CA1h, and CA1a) were immuno-
stained with Repo-Man antibody and costained with DAPI.
(B) The cell lines in (A) were assayed by western blotting for
Repo-Man and b-actin.
(C) T1k and CA1h cells were treated with etoposide at the
indicated concentrations for 16 hr and analyzed by fluores-
cence-activated cell sorting (FACS) to determine the
percentage of cells in the G2/M phase. The actual G2/M
percentages of etoposide-treated T1k and CA1h cells were
normalized to those of control T1k and CA1h cells without
etoposide treatment for a relative G2/M index. Increases in
the G2/M index reflect etoposide-induced activation of the
G2/M checkpoint. The mean6SEM (n = 3) of replicate exper-
iments is shown.
(D) Tlk and CA1h cells treated with 250 nM etoposide were
analyzed by western blotting for DDR signaling, as indicated
by ATM and Chk1 phosphorylation.
(E) T1k cells were infected with recombinant adenovirus ex-
pressing either GFP or GFP-Repo-Man. These cells were
then treated with 250 nM etoposide and analyzed by FACS
for cell-cycle arrest as in (C).
(F) Cells in (E) were analyzed by western blotting with the
indicated antibodies.
(G) CA1h cells were transfected with control small interfering
RNA (siRNA) (C) or two different Repo-Man siRNAs (1 and 2),
treated with 250 nM etoposide, and analyzed by western
blotting for the indicated proteins. See also Figure S5.
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392[32, 33]. These results prompted us to test whether Repo-Man
overexpression is generally evident during cancer progression.
Using immunohistochemistry, we observed enhanced expres-
sion of Repo-Man in many, but not all, cancer tissues as
compared to adjacent normal tissues (Figures S5A and S5B).
As summarized in Figure S5C, significantly increased Repo-
Man expression was found in roughly half of all cancer tissues
tested. To extend this analysis, we obtained a series of staged
and graded human breast tumors and matched normal tissues.
As shown in Figure S5D, analysis in these tissue lysates shows
that Repo-Man was frequently overexpressed in late stage and
higher-grade tumors. Consistently, Repo-Man level was alsoelevated in a panel of tumorigenic breast cancer
cell lines compared to nontumorigenic lines (Fig-
ure S5E). Finally, the National Cancer Institute-
supported mRNA expression database (http://
www.oncomine.org;) shows that Repo-Man tran-
scription is frequently upregulated in various
cancers (Figure S5F). We thus speculate that in-
creased Repo-Man levels during cancer progres-
sion result at least partly from activated gene tran-
scription. Taken together, a comprehensive set of
evidence shows that Repo-Man is overexpressed
in a large proportion of late-stage cancers.
Elevated Repo-Man Expression Blunts the
DNA Damage Response during Cancer
Progression
To investigate whether overexpression of Repo-
Man renders early-stage tumor cells less sensitive
to DNA damage, we analyzed the well-established
MCF10A human breast cancer model system con-
sisting of a series of transformed mammary
epithelial cell (MEC) lines that share a common
genetic ancestry. Each line represents a distinctstage of breast cancer development, ranging from normal
(i.e., MCF10A) to premalignant (i.e., MCF10A-T1k) to malignant
(i.e., MCF10A-CA1h) to invasive and metastatic (i.e., MCF10A-
CA1a) [34]. These lines can be studied in cell culture and also
as human tumor xenografts in nude mice. Extensive gene
array, SAGE, and single-nucleotide polymorphism analyses
have indicated that this system accurately recapitulates the
genetic changes that are found during human breast cancer
progression [35, 36]. Interestingly, expression of Repo-Man
is greatly elevated during the transition from T1k to CA1h, as
confirmed by both immunofluorescence and western blotting
(Figures 6A and 6B). In concert with this change in Repo-Man
A Control RNAi                             Repo-Man RNAi
B GFP                                         GFP-Repo-Man
 GFP-Repo-Man
C
D
ATM
g-H2AX
PP1g
Repo-Man
DNA damage checkpoint activation
DSB
Figure 7. Repo-Man Expression Is Required for Growth of T1k Cells in Soft
Agar
(A) CA1h cells treated with control or Repo-Man small hairpin RNA were
grown on standard tissue culture dishes (top) or in soft agar for 14 days.
Representative pictures of the colonies formed in soft agar are shown
(bottom).
(B and C) T1k cells were infected with adenovirus encoding GFP or GFP-
Repo-Man and then grown in soft agar. Representative pictures of the
colonies formed after 14 days are shown. As indicated by arrows, the larger
colony (C, top) was expressing GFP-Repo-Man, as detected by direct GFP
fluorescence (C, bottom).
(D) A model in which Repo-Man recruits PP1g to chromatin to antagonize
activation of ATM-dependent signal transduction. The Repo-Man-depen-
dent DDR regulation illustrated in this model is strengthened by Repo-Man
overexpression during cancer progression, resulting in reduced DDR sensi-
tivity. See also Figure S6.
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393level, the DDR to etoposide in malignant CA1h cells is less
sensitive than that in premalignant T1k cells, as judged by
both phosphorylation of DDR components and G2/M arrest
(Figures 6C and 6D). Importantly, ectopic expression of
Repo-Man significantly reduced the DDR in T1k cells to the
CA1h level (Figures 6E and 6F), indicating that upregulation
of Repo-Man is sufficient for the reduced DDR in CA1h cells.
Conversely, knockdown of Repo-Man expression resensitized
the DDR in late-stage cancer cells, including CA1h (Figure 6G)
and CA1a in the MCF10A breast cancer model, and also in BT-
20, a well-established breast cancer cell line initially derived
from an advanced invasive ductal carcinoma (Figure S6A).
These results confirm the critical role of Repo-Man in modu-
lating DNA damage signaling.
Repo-Man Expression Is Required for CA1h Cell Growth in
Soft Agar
To assess whether upregulation of Repo-Man is necessary to
promote tumorigenesis, we studied growth of tumor cells in
soft agar assays. Malignant CA1h cells grow into large colo-
nies in soft agar, whereas precancerous T1k cells only form
very small ones. Interestingly, CA1h cells stably infected with
lentiviral small hairpin RNA (shRNA) that knocks down Repo-
Man expression were unable to form large colonies in soft
agar (Figure 7A; Figure S6B), despite little effect on prolifera-
tion in regular culture. On the other hand, ectopic expression
of Repo-Man was not sufficient to promote soft agar growth
of T1k, although some increase in colony size was evident
(Figures 7B and 7C). Therefore, upregulation of Repo-Man is
necessary but not sufficient for anchorage-independent/soft
agar growth in the MCF10A breast cancer model.
Discussion
Serine/threonine phosphatases are less studied compared to
their functional counterparts, serine/threonine kinases. Both
PP1 and PP2A rely on additional targeting subunits to perform
specific functions. Recent publications have begun to identify
these targeting subunits and the underlying mechanisms and
to present an attractive picture in which the complexity, spec-
ificity, and importance of protein phosphatases are generally
comparable to that of protein kinases [10, 11]. In the DDR
pathway, several groups of protein phosphatases have been
shown to dephosphorylate DDR components and promote
recovery from checkpoint arrest. Some key questions,
however, remain to be answered. For example, do protein
phosphatases regulate the initial activation of the DDR, and
how is regulation specifically achieved? In this study, we
show that inhibition of PP1 and PP2A efficiently turns on
DDR signaling in Xenopus egg extracts. These findings under-
score the essential role of both PP1 and PP2A in suppression
of the DDR. The involvement of PP2A reported here supports
its previously revealed role as an important DDR regulator
that promotes checkpoint recovery through dephosphoryla-
tion of multiple DDR factors, including H2AX, Chk2, Chk1,
ATM, and p53, etc. [9, 14–16]. Data presented here clearly indi-
cate that PP1 also plays a critical role in DDR regulation. Inhi-
bition of PP2A or PP1 alone is not sufficient to activate DDR
signaling, but simultaneous inhibition of both phosphatases
fully turns on the DDR. Moreover, inhibition of PP1 results in
a sensitized response to DNA damage. This study reveals
the first specific PP1-dependent regulation of the DDR medi-
ated by a chromatin-bound targeting subunit, Repo-Man.
Importantly, Repo-Man interacts with PP1 and ATM throughdistinct motifs, thus targeting PP1g to antagonize ATM activa-
tion and negatively regulate DNA damage-induced signal
transduction. In this scenario, Repo-Man controls both the
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394localization and substrate specificity of the PP1 holoenzyme
complex and sets the threshold for checkpoint activation in
both Xenopus oocytes and egg extracts (Figure 7D). The func-
tional relationship between ATM and Repo-Man was further
strengthened by studies in human cells. Repo-Man associates
with ATM and extensively colocalizes with ATM on chromatin.
Overexpression of Repo-Man in cells reduces DNA damage-
induced ATM activation, whereas a PP1 binding-deficient
Repo-Man dominant-negative mutant enhances the response.
Another important question regarding specific phosphatase
complexes is how they are regulated by DNA damage. We
report here that Repo-Man is released from DNA damage sites
and dissociated from active ATM, presumably to facilitate DDR
activation by DNA damage above the threshold level. This is
a striking result because it argues that activation of the DDR
involves removal of inhibitory regulators. Though the under-
lying mechanism is unclear, the chromatin dissociation of
Repo-Man-PP1 may be phosphorylation dependent, because
MC treatment removed PP1 and Repo-Man from chromatin
(data not shown).
The DDR pathway is essential to protect genomic stability
and suppress tumorigenesis. Inherited mutations in DDR
factors, including ATM, Chk1, Chk2, Mre11, Nbs1, etc., predis-
pose patients to various cancers. However, most cancer
patients are born with an intact DDR pathway, and little is
known about how their tumor cells escape from the DDR.
Recent reports show that the DDR is activated in early,
precancerous cells as a barrier to suppress cell proliferation
and cancer progression [2]. DDR activation is greatly reduced
in late-stage cancer cells, presumably resulting in uncon-
trolled cell proliferation [2, 37, 38]. The mechanism of this
modulation in DNA damage responsiveness is unknown. Our
study presented here discovered a mechanism that may
contribute to this process. We found that Repo-Man expres-
sion is significantly enhanced in many, although not all,
cancers. Repo-Man overexpression is sufficient to modulate
DDR sensitivity during progression of cancer because
elevated Repo-Man blunted the DDR in early-stage precan-
cerous cells and, conversely, knockdown of Repo-Man
restored DDR sensitivity in advanced-stage cancer cells. We
propose that during early stages of cancer progression, the
DDR is activated in response to elevated genomic instability
to prevent further cell proliferation. Such a process poses
a selection pressure for cells with a reduced DDR, such as
those in which Repo-Man is upregulated. These cells resume
proliferation bearing a high level of spontaneous DNA
damage, resulting in acquisition of additional mutations and
further cancer progression. The involvement of Repo-Man in
cancer progression is supported by the soft agar assay
showing that Repo-Man expression is essential for colony
formation. However, several aspects of this model still remain
to be further clarified. For example, it is unclear whether Repo-
Man upregulation is a consequence of oncogenic stimuli.
Moreover, although not all cancers exhibit Repo-Man overex-
pression, a similar deregulation of the DDR could be achieved
in some cancers through parallel mechanisms that involve
other protein phosphatase complexes [12, 14, 16, 39]. Of
particular interest to us, inhibition of PP1, PP2A, or PP2Cd/
Wip1 has been shown to affect cell survival post radiation or
after chemotherapy (reviewed in [40]). We report here that
merely reducing Repo-Man expression resensitized advanced
cancer cells to the DDR and restrained their growth, suggest-
ing that Repo-Man may be a potentially valuable target in
cancer therapy.Experimental Procedures
cDNA Cloning of Xenopus Repo-Man
Total RNA was extracted from Xenopus laevis oocytes with a QuickPrep
total RNA extraction kit (Amersham) following the protocol recommended
by the manufacturer. The 50 and 30 sequences of Xenopus Repo-Man
were determined by rapid amplification of cDNA ends (RACE) with a SMART
RACE cDNA amplification kit (Clontech). The full-length cDNA of Xenopus
Repo-Man was then generated by end-to-end polymerase chain reaction
(with primers 50-ATCTCCAGAAAGGTTTTGCAGGAG-30 and 50-AATGTAA
CGGTCCATGGGTTCTGC-30). The sequence has been deposited in Gen-
Bank under accession number FJ532285.
Cell Extraction and Chromatin Fiber
Cell extraction was carried out via a protocol described previously, with
minor modifications [41]. Cells on coverglasses were treated with extraction
buffer (0.5% NP40 in phosphate-buffered saline [PBS]) for 5 min on ice and
washed once with extraction buffer and twice with PBS. Immunostaining
was then performed as described below. Chromatin fibers were generated
following a previously established protocol [42]. Briefly, 2 3 105 cells were
resuspended in 0.5% sodium citrate for 10 min and spun onto a coverglass.
The coverglass was then dipped in salt/detergent buffer (25 mM Tris 7.5,
500 mM NaCl, 1% Triton X-100) for 10 min and removed for immunostaining.
Chromatin Fractionation
As described previously [6], to reisolate sperm chromatin from egg extracts,
extracts were diluted 10-fold with chromatin dilution buffer (50 mM HEPES,
pH 7.5, 50 mM KCl, 5 mM MgCl2, 2 mM DTT, 0.5 mM spermine 3 HCl,
0.15 mM spermine 4 HCl, 0.1% Triton X-100). The diluted extract was then
layered onto 3 ml of chromatin dilution buffer containing 30% sucrose and
centrifuged at 60003 g for 15 min. The pellet was resuspended as the chro-
matin-enriched fraction.
Repo-Man Knockdown
Small interfering RNA (siRNA) duplexes targeting human Repo-Man (target
sequences UCAGAAGCAUGCCGAAUUA and GUUCAAAGGCUACCGGA
GA) and a nontargeting control siRNA were purchased from Dharmacon
and transfected into CA1h, CA1a, or BT-20 cells, following the protocol rec-
ommended by the manufacturer. Lentiviral shRNAs targeting Repo-Man
were utilized to infect CA1h cells, following the protocol recommended by
the manufacturer (Sigma, NM_152562). Morpholino antisense oligonucleo-
tides targeting Xenopus Repo-Man were designed and produced by
Gene Tools. Both morpholino oligonucleotides (TCTGGAAGTCATCACCT
CCTCTCCA and AGATTCAAATTCAAATCTGCCGCCG) were suspended in
nuclease-free water to a concentration of 0.1 mM, and 40 nl was injected
into each oocyte.
Soft Agar Assay
The growth of T1k and CA1h cells in soft agar was performed as described
[43]. In brief, cells (10,000 cells per plate) were grown in 0.3% agar on
a cushion of 0.6% agar in 35 mm plates for 14 days, after which the colonies
were observed under a light microscope.
Xenopus Oocytes and Cytostatic Factor Extracts
Oocyte maturation was induced in vitro by addition of progesterone
(10 mg/ml), and entry into M phase was monitored by germinal vesicle break-
down with a dissecting microscope, as described previously [6]. Cytostatic
factor extracts, prepared as previously described [6], were stably released
into interphase by supplementation with 0.4 mM CaCl2 and 100 mg/ml cyclo-
heximide, followed by incubation for 30 min at room temperature prior to
use. Oocyte extracts were generated by homogenization of the oocytes, fol-
lowed by centrifugation at 15,000 3 g for 4 min at 4C. NCS was purchased
from Sigma and used to generate DNA DSBs in extracts at concentrations
indicated in the figure legends. Extracts used in this study were supple-
mented with 1,000 demembranated sperm nuclei/ml, unless otherwise
indicated. I-2 and MC were purchased from New England Biolabs and Cal-
biochem, respectively.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.cub.
2010.01.020.
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